Related references
Note: Only part of the references are listed.Protein tyrosine phosphatase PTPN22 negatively modulates platelet function and thrombus formation
Xiamin Wang et al.
BLOOD (2022)
Assessment of a complete and classified platelet proteome from genome-wide transcripts of human platelets and megakaryocytes covering platelet functions
Jingnan Huang et al.
SCIENTIFIC REPORTS (2021)
Catalytic dysregulation of SHP2 leading to Noonan syndromes affects platelet signaling and functions
Marie Bellio et al.
BLOOD (2019)
Platelet biology and functions: new concepts and clinical perspectives
Paola E. J. van der Meijden et al.
NATURE REVIEWS CARDIOLOGY (2019)
Megakaryocyte-specific deletion of the protein-tyrosine phosphatases Shp1 and Shp2 causes abnormal megakaryocyte development, platelet production, and function
Alexandra Mazharian et al.
BLOOD (2013)
Dominant Role of the Protein-Tyrosine Phosphatase CD 148 in Regulating Platelet Activation Relative to Protein-Tyrosine Phosphatase-1B
Jun Mori et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis
Yotis A. Senis et al.
BLOOD (2009)
PTP-1B is an essential positive regulator of platelet integrin signaling
EG Arias-Salgado et al.
JOURNAL OF CELL BIOLOGY (2005)
Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3
MAH Feijge et al.
BIOCHEMICAL PHARMACOLOGY (2004)